This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

M. Curtis, MD; M. J. Gill, MB, FRCPC; A.K.W. Brownell, MD, FRCPC
The University of Calgary Calgary, Alberta, Canada T2N 4N1

Arch Neurol. 1989;46(8):841.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—we cared for a 29-year-old homosexual man with acquired immunodeficiency syndrome who developed severe myalgias and muscle weakness while being treated with zidovudine (Retrovir, formerly called AZT or azidothymidine). Within 10 days of the onset of his symptoms, acute high-output renal failure secondary to myoglobinuria developed. The creatinine level was greater than 1200 µmol/L, the creatine kinase level was greater than 12000 U, and the urine was orthotolidine positive in the absence of red blood cells. A skeletal muscle biopsy specimen showed scattered necrotic muscle fibers, occasional internal nuclei, and a few rodlike structures. No inflammation was noted. Viral particles were not seen on examination of the muscle using electron microscopy, and no viruses could be grown on viral culture.

The patient had been stable on 600 mg/d of zidovudine for 7 months before symptoms developed. Except for the 17-day period when the patient was too . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?